Arbutus Biopharma Corp (ABUS) — Strategic Asset Allocation Index
Arbutus Biopharma Corp (ABUS) has a Strategic Asset Allocation Index of 0.0% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $97.37 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check ABUS asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Arbutus Biopharma Corp Strategic Asset Allocation Index (2000–2024)
This chart shows how Arbutus Biopharma Corp's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2024. As of December 2024, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $97.37 Million USD. See ABUS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Arbutus Biopharma Corp (2000–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Arbutus Biopharma Corp from 2000 to 2024, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Arbutus Biopharma Corp worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $0.00 | $- | $0.00 | $97.37 Million | ▼ -5.9 pp |
| 2023 | 5.9% | $6.28 Million | $- | $6.28 Million | $106.02 Million | ▼ -25.1 pp |
| 2022 | 31.0% | $42.43 Million | $5.07 Million | $37.36 Million | $136.85 Million | ▲ +6.4 pp |
| 2021 | 24.6% | $41.67 Million | $5.98 Million | $35.69 Million | $169.44 Million | ▲ +17.8 pp |
| 2020 | 6.8% | $6.93 Million | $6.93 Million | $0.00 | $101.97 Million | ▼ -5.1 pp |
| 2019 | 11.9% | $8.68 Million | $8.68 Million | $0.00 | $72.74 Million | ▼ -4.2 pp |
| 2018 | 16.2% | $32.37 Million | $10.14 Million | $22.22 Million | $200.23 Million | ▲ +9.5 pp |
| 2017 | 6.7% | $12.18 Million | $12.18 Million | $0.00 | $182.50 Million | ▲ +3.3 pp |
| 2016 | 3.4% | $6.95 Million | $6.95 Million | $0.00 | $203.00 Million | ▲ +1.0 pp |
| 2015 | 2.4% | $13.25 Million | $3.18 Million | $10.07 Million | $547.68 Million | ▲ +0.4 pp |
| 2014 | 2.0% | $1.76 Million | $1.76 Million | $- | $88.00 Million | ▼ -0.3 pp |
| 2013 | 2.3% | $1.37 Million | $1.37 Million | $- | $59.19 Million | ▼ -1.0 pp |
| 2012 | 3.3% | $1.36 Million | $1.36 Million | $0.00 | $40.92 Million | ▼ -38.1 pp |
| 2011 | 41.4% | $2.15 Million | $2.15 Million | $0.00 | $5.21 Million | ▲ +12.3 pp |
| 2010 | 29.1% | $3.12 Million | $3.12 Million | $0.00 | $10.73 Million | ▲ +21.6 pp |
| 2009 | 7.5% | $2.67 Million | $2.67 Million | $0.00 | $35.44 Million | ▲ +1.9 pp |
| 2008 | 5.6% | $2.14 Million | $2.14 Million | $0.00 | $38.29 Million | ▼ -2.7 pp |
| 2007 | 8.3% | $1.53 Million | $1.53 Million | $0.00 | $18.37 Million | ▼ -313.2 pp |
| 2006 | 321.5% | $500.04K | $500.04K | $0.00 | $155.53K | ▲ +312.1 pp |
| 2003 | 9.4% | $4.10 Million | $4.10 Million | $0.00 | $43.38 Million | ▲ +1.2 pp |
| 2002 | 8.3% | $3.75 Million | $3.75 Million | $0.00 | $45.35 Million | ▲ +3.7 pp |
| 2001 | 4.5% | $2.79 Million | $2.79 Million | $0.00 | $61.49 Million | ▼ -3.6 pp |
| 2000 | 8.1% | $2.44 Million | $2.44 Million | $0.00 | $30.03 Million | — |